日本皮膚科学会雑誌
Online ISSN : 1346-8146
Print ISSN : 0021-499X
日本皮膚科学会ガイドライン
疥癬診療ガイドライン(第2版)
石井 則久朝比奈 昭彦天谷 雅行飯島 正文石川 治今村 英一大江 麻里子大滝 倫子加藤 安彦金澤 伸雄上出 良一神崎 保木花 光小茂田 昌代杉山 奈津子関根 万里竹崎 伸一郎田中 勝田村 暢子永岡 譲南光 弘子林 正幸牧上 久仁子松田 知子吉住 順子和田 康夫
著者情報
ジャーナル 認証あり

2007 年 117 巻 1 号 p. 1-13

詳細
抄録

Guideline has been prepared by the Japanese Dermatological Association to ensure proper diagnosis and treatment of scabies, as oral therapy became available on August, 2006 under health insurance and its clinical use was expected to increase. For making proper diagnosis following three points should be taken into consideration, clinical findings, detection of the mite (Sarcoptes scabiei var. hominis), and epidemiological findings. The diagnosis is confirmed if the mites or eggs are identified by microscopic examinations or dermatoscopy examination. Sulfur-containing ointments, with only limited usefulness, are only available drugs approved by health insurance coverage for treating scabies. Currently crotamiton cream, benzyl benzoate lotion, and γ-BHC ointment are also used clinically. It is important to apply the ointment to the whole body, including hands, fingers and genitals. The dosage for ivermectin is a single oral administration of approximately 200 µg/kg body weight with water on an empty stomach. Administration of a second dose is considered, if new specific lesions develop or the mites are detected. For treating hyperkeratotic (crusted or Norwegian) scabies, concomitant administration of oral ivermectin and the topical ointments as well as removal of thick scabs and infected regions in nails should be considered. Some safe and useful ointments are needed to be approved by health insurance

著者関連情報
© 2007 日本皮膚科学会
次の記事
feedback
Top